PART I All references in this report to Dermata, the Company, we, us, or our mean Dermata Therapeutics, Inc. unless stated otherwise or the context otherwise indicates. Overview We are a scientific leader in skincare, dedicated to the development and commercialization of products that address common and underserved skin conditions. Dermata initially was founded with a focus on researching and developing prescription products subject to the FDA approval process. As part of this focus, we had one ...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001493152-26-012992 | EDGAR | 96K words |
| 2025-03-17 | 2024-12-31 | 0001654954-25-002885 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0001654954-24-003501 | EDGAR | — |
| 2023-02-21 | 2022-12-31 | 0001654954-23-001926 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001654954-22-003869 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001493152-25-023474 | EDGAR | 25K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023572 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010111 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001654954-24-014274 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001654954-24-010103 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001654954-24-006398 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001654954-23-014016 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001654954-23-010487 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001654954-23-006208 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001654954-22-015035 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001654954-22-011375 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001654954-22-006966 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001493152-26-036109 | EDGAR | — |
| 2026-03-26 | 0001493152-26-012991 | EDGAR | 2K words |
| 2026-02-25 | 0001493152-26-008037 | EDGAR | — |
| 2026-02-03 | 0001493152-26-004905 | EDGAR | — |
| 2026-01-27 | 0001493152-26-003715 | EDGAR | — |
| 2025-12-29 | 0001493152-25-029364 | EDGAR | — |
| 2025-11-18 | 0001493152-25-023942 | EDGAR | — |
| 2025-11-14 | 0001493152-25-023419 | EDGAR | — |
| 2025-11-07 | 0001493152-25-021255 | EDGAR | — |
| 2025-09-17 | 0001493152-25-013815 | EDGAR | — |
124 total filings indexed. 97 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001853816 |
| Ticker | DRMA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.dermatarx.com |
| Listed | 2021-08-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DRMA (~200 tokens, structured JSON with cryptographic provenance)